Technical Analysis for GH - Guardant Health, Inc.

Grade Last Price % Change Price Change
grade B 88.14 -0.37% -0.33
GH closed down 0.37 percent on Monday, June 24, 2019, on 47 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Up Down
See historical GH trend table...

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
MACD Bearish Signal Line Cross Bearish -0.37%
Multiple of Ten Bearish Other -1.63%
Slingshot Bullish Bullish Swing Setup -1.50%
Multiple of Ten Bearish Other -1.50%
Shooting Star Candlestick Bearish -3.26%
Pocket Pivot Bullish Swing Setup -3.26%
Doji - Bearish? Reversal -3.26%
Wide Bands Range Expansion -3.26%

Older signals for GH ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Its Guardant Health Oncology Platform is designed to leverage its capabilities in technology, clinical development, regulatory and reimbursement to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs. In pursuit of its goal to manage cancer across all stages of the disease, Guardant Health has launched multiple liquid biopsy-based tests, Guardant360 and GuardantOMNI, for advanced stage cancer patients, which fuel its development programs for recurrence and early detection, LUNAR-1 and LUNAR-2, respectively. Since its launch in 2014, Guardant360 has been used by more than 5,000 oncologists, over 40 biopharmaceutical companies and all 27 of the National Comprehensive Cancer Network centers.
Medicine Biopharmaceutical Cancer Medical Specialties Disease Oncology Precision Medicine
Is GH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 106.58
52 Week Low 27.04
Average Volume 1,185,183
200-Day Moving Average 0.0
50-Day Moving Average 76.9398
20-Day Moving Average 85.8965
10-Day Moving Average 88.971
Average True Range 3.8789
ADX 31.54
+DI 29.0113
-DI 19.3716
Chandelier Exit (Long, 3 ATRs ) 82.8033
Chandelier Exit (Short, 3 ATRs ) 82.98669999999999
Upper Bollinger Band 95.8962
Lower Bollinger Band 75.8968
Percent B (%b) 0.61
BandWidth 23.283137
MACD Line 3.714
MACD Signal Line 4.0841
MACD Histogram -0.3701
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 91.72
Resistance 3 (R3) 91.68 90.43 91.13
Resistance 2 (R2) 90.43 89.52 90.46 90.93
Resistance 1 (R1) 89.29 88.96 88.67 89.33 90.73
Pivot Point 88.04 88.04 87.73 88.07 88.04
Support 1 (S1) 86.90 87.13 86.28 86.95 85.55
Support 2 (S2) 85.65 86.57 85.68 85.35
Support 3 (S3) 84.51 85.65 85.15
Support 4 (S4) 84.56